Editorial
Published 2020-12-01
Keywords
- personalized medicine,
- personalization,
- targeted therapies
How to Cite
1.
Lawler P, Miao W, Williams P. From the Editor’s Desk: The emergence of "personalized medicine" in medical care. McGill J Med [Internet]. 2020 Dec. 1 [cited 2025 Oct. 6];10(1). Available from: https://mjm.mcgill.ca/article/view/628

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Abstract
N/A
Downloads
Download data is not yet available.
References
- Haydon AM, Jass JR. Emerging pathways in colorectal-cancer development. The Lancet Oncology 2002; 3:83-8.
- Yashiro M, et al. Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Research 2001; 61:2676-83.
- Slamon DJ, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 1987; 235:177-82.
- Slamon, D.J. et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New England Journal of Medicine 2001; 344:783-792
- Seshadri, R. et al. Clinical significance of HER-2/neu oncogene amplification in primary breast cancer Journal of Clinical Oncology 1993; 11: 1936-1942.